CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 56 enrolled
Drug / intervention
Liftbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04581200
NCT04581200N/ACompleted
CompareCT.gov

Addressing Psychological Distress Symptoms Among Serious Illness Survivors of a Viral Pandemic With a Completely Self-directed, Symptom-responsive Mobile Mindfulness Intervention: a Randomized Controlled Trial

Duke University·interventional·Posted Oct 9, 2020·Updated Nov 7, 2023

In Brief

A clinical study evaluating Lift for COVID-19 and Cardiorespiratory Failure. Completed, enrolled 56 participants across 4 sites.

Detailed Summary

This is a randomized clinical trial (RCT) nested within the NIH PETAL Network's COVID cohort study (BLUE CORAL \[Biology and Longitudinal Epidemiology: COVID Observational Study\]) of patients hospitalized for COVID-19-related illness. COVID-19 patients enrolled in BLUE CORAL with elevated distress symptoms 1 month post-discharge will be randomized to either the Lift mobile app intervention or a usual care control.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCOVID-19, Cardiorespiratory Failure
CountriesUnited States
CollaboratorsNational Center for Complementary and Integrative Health (NCCIH)

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedOct 9, 2020
Enrollment StartJan 25, 2021
Primary CompletionMar 30, 2022
Study CompletionMay 30, 2022
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 5.7 years ago

Interventions

Liftbehavioral

The intervention is a mobile app-based mindfulness training program designed to be used over a 1-month period.